miR-218-5p inhibits the stem cell properties and invasive ability of the A2B5+CD133− subgroup of human glioma stem cells

MicroRNAs (miRs) act as oncogenes or tumor-suppressor genes, and regulate the proliferation, apoptosis, invasion, differentiation, angiogenesis and behavior of glioma stem cells, which are important in glioma development and recurrence. The present study was performed to investigate the impact of mi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncology reports 2016-02, Vol.35 (2), p.869-877
Hauptverfasser: WU, ZHIWU, HAN, YONG, LI, YANYAN, LI, XUETAO, SUN, TING, CHEN, GUILIN, HUANG, YULUN, ZHOU, YOUXIN, DU, ZIWEI
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 877
container_issue 2
container_start_page 869
container_title Oncology reports
container_volume 35
creator WU, ZHIWU
HAN, YONG
LI, YANYAN
LI, XUETAO
SUN, TING
CHEN, GUILIN
HUANG, YULUN
ZHOU, YOUXIN
DU, ZIWEI
description MicroRNAs (miRs) act as oncogenes or tumor-suppressor genes, and regulate the proliferation, apoptosis, invasion, differentiation, angiogenesis and behavior of glioma stem cells, which are important in glioma development and recurrence. The present study was performed to investigate the impact of miR-218-5p on stem cell properties and invasive ability of the A2B5+CD133− human glioma stem cell subgroup. qRT-PCR was used to detect miR-218-5p expression in non-cancerous brain and human glioma tissues, human glioma cell lines and human glioma stem cell lines. Lentivirus vectors encoding miR-218-5p and anti-miR-218-5p were constructed and stably transfected into A2B5+CD133− SHG-139s cells. Neurosphere formation Cell Counting Kit-8 (CCK-8) and Transwell assays, immunofluorescence and qRT-PCR analyses were used to explore the role of miR-218-5p in SHG-139s cells. qRT-PCR analysis showed that miR-218-5p expression was lower in human glioma tissues and cells than in non-cancerous brain tissues and normal human astrocyte cells, and lower in A2B5+CD133− (SHG-139s) cells than in CD133+ (SU2 and U87s) cells. The CCK-8 assay demonstrated that the growth curve was significantly inhibited in the miR-218-5p-SHG-139s cells compared to the miR-control, blank and anti-miR-218-5p groups. The neurosphere formation assay indicated that upregulation of miR-218-5p expression inhibited SHG-139s neurosphere formation. Immunofluorescence staining and qRT-PCR showed that miR-218-5p reduced stem cell marker (A2B5, nestin, PLAGL2, ALDH1 and Sox2) expression compared with the controls; however, immunofluorescence staining analysis showed that upregulation of miR-218-5p expression led to no difference in CD133 expression. miR-218-5p reduced SHG-139s cell invasiveness in the Transwell assay and reduced MMP9 expression as detected in qRT-PCR and immunofluorescence analyses. All differences were statistically significant. miR-218-5p expression was lower in human glioma tissues, cells and the A2B5+CD133− human glioma stem cell subgroup. miR-218-5p may be a tumor-suppressor gene in glioma that functions by upregulating miR-218-5p expression, which inhibits the stem cell properties and invasive properties of SHG-139s cells.
doi_str_mv 10.3892/or.2015.4418
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1752351204</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1752351204</sourcerecordid><originalsourceid>FETCH-LOGICAL-c318t-4d8f5a22d9a45f10ef4b7b153a2c790b42ee470ce892303e86bfdfb56cc210b93</originalsourceid><addsrcrecordid>eNpd0d9r1TAUB_AgipvTN58lIIjgcs05SdrmcV5_TBgIouBbSdp0N6NtuqQdzL_A5_2J_iVLvXOCTwnkk8M550vIc-AbUWl8G-IGOaiNlFA9IIdQamAoBTzMd47AhFA_DsiTlC44x5IX-jE5wEKVCEV5SH4O_itDqJiaqB933vo50XnnaJrdQBvX93SKYXJx9i5RM7ZZXZnkrxw11vd-vqah-_PhBN-pN9v3IMTvXzc0LfY8hmVaX3fLYEZ63vswmH9101PyqDN9cs_uziPy_eOHb9tTdvbl0-ftyRlrBFQzk23VKYPYaiNVB9x10pYWlDDYlJpbic7JkjcuL0Nw4arCdm1nVdE0CNxqcURe7-vmQS4Xl-Z68GntwIwuLKmGUqFQgFxm-vI_ehGWOObuatACi0pqpbI63qsmhpSi6-op-sHE6xp4vWZSh1ivmdRrJpm_uCu62MG19_hvCBm82oM05QX7NqR7EyITinFkvCq0uAUrJZMF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1932684955</pqid></control><display><type>article</type><title>miR-218-5p inhibits the stem cell properties and invasive ability of the A2B5+CD133− subgroup of human glioma stem cells</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>WU, ZHIWU ; HAN, YONG ; LI, YANYAN ; LI, XUETAO ; SUN, TING ; CHEN, GUILIN ; HUANG, YULUN ; ZHOU, YOUXIN ; DU, ZIWEI</creator><creatorcontrib>WU, ZHIWU ; HAN, YONG ; LI, YANYAN ; LI, XUETAO ; SUN, TING ; CHEN, GUILIN ; HUANG, YULUN ; ZHOU, YOUXIN ; DU, ZIWEI</creatorcontrib><description>MicroRNAs (miRs) act as oncogenes or tumor-suppressor genes, and regulate the proliferation, apoptosis, invasion, differentiation, angiogenesis and behavior of glioma stem cells, which are important in glioma development and recurrence. The present study was performed to investigate the impact of miR-218-5p on stem cell properties and invasive ability of the A2B5+CD133− human glioma stem cell subgroup. qRT-PCR was used to detect miR-218-5p expression in non-cancerous brain and human glioma tissues, human glioma cell lines and human glioma stem cell lines. Lentivirus vectors encoding miR-218-5p and anti-miR-218-5p were constructed and stably transfected into A2B5+CD133− SHG-139s cells. Neurosphere formation Cell Counting Kit-8 (CCK-8) and Transwell assays, immunofluorescence and qRT-PCR analyses were used to explore the role of miR-218-5p in SHG-139s cells. qRT-PCR analysis showed that miR-218-5p expression was lower in human glioma tissues and cells than in non-cancerous brain tissues and normal human astrocyte cells, and lower in A2B5+CD133− (SHG-139s) cells than in CD133+ (SU2 and U87s) cells. The CCK-8 assay demonstrated that the growth curve was significantly inhibited in the miR-218-5p-SHG-139s cells compared to the miR-control, blank and anti-miR-218-5p groups. The neurosphere formation assay indicated that upregulation of miR-218-5p expression inhibited SHG-139s neurosphere formation. Immunofluorescence staining and qRT-PCR showed that miR-218-5p reduced stem cell marker (A2B5, nestin, PLAGL2, ALDH1 and Sox2) expression compared with the controls; however, immunofluorescence staining analysis showed that upregulation of miR-218-5p expression led to no difference in CD133 expression. miR-218-5p reduced SHG-139s cell invasiveness in the Transwell assay and reduced MMP9 expression as detected in qRT-PCR and immunofluorescence analyses. All differences were statistically significant. miR-218-5p expression was lower in human glioma tissues, cells and the A2B5+CD133− human glioma stem cell subgroup. miR-218-5p may be a tumor-suppressor gene in glioma that functions by upregulating miR-218-5p expression, which inhibits the stem cell properties and invasive properties of SHG-139s cells.</description><identifier>ISSN: 1021-335X</identifier><identifier>EISSN: 1791-2431</identifier><identifier>DOI: 10.3892/or.2015.4418</identifier><identifier>PMID: 26572167</identifier><language>eng</language><publisher>Greece: D.A. Spandidos</publisher><subject>A2B5+CD133− glioma stem cells ; Adult ; Brain Neoplasms - genetics ; Brain Neoplasms - pathology ; Brain research ; Cancer therapies ; Cell Line, Tumor ; Cell Proliferation - genetics ; Chemotherapy ; Cloning ; Female ; Fluorescent Antibody Technique ; Gene Expression Regulation, Neoplastic - genetics ; Gene Knockdown Techniques ; Genes ; Genes, Tumor Suppressor ; Genotype &amp; phenotype ; Glioma ; Glioma - genetics ; Glioma - pathology ; Growth factors ; Humans ; invasive ability ; Laboratories ; Male ; Medical research ; MicroRNAs - genetics ; Middle Aged ; miR-218-5p ; Neoplasm Invasiveness ; Neoplastic Stem Cells - pathology ; Patients ; Penicillin ; Polymerase Chain Reaction ; stem cell properties ; Stem cells ; Studies ; Surgery ; Transfection ; Tumors</subject><ispartof>Oncology reports, 2016-02, Vol.35 (2), p.869-877</ispartof><rights>Copyright: © Wu et al.</rights><rights>Copyright Spandidos Publications UK Ltd. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c318t-4d8f5a22d9a45f10ef4b7b153a2c790b42ee470ce892303e86bfdfb56cc210b93</citedby><cites>FETCH-LOGICAL-c318t-4d8f5a22d9a45f10ef4b7b153a2c790b42ee470ce892303e86bfdfb56cc210b93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26572167$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>WU, ZHIWU</creatorcontrib><creatorcontrib>HAN, YONG</creatorcontrib><creatorcontrib>LI, YANYAN</creatorcontrib><creatorcontrib>LI, XUETAO</creatorcontrib><creatorcontrib>SUN, TING</creatorcontrib><creatorcontrib>CHEN, GUILIN</creatorcontrib><creatorcontrib>HUANG, YULUN</creatorcontrib><creatorcontrib>ZHOU, YOUXIN</creatorcontrib><creatorcontrib>DU, ZIWEI</creatorcontrib><title>miR-218-5p inhibits the stem cell properties and invasive ability of the A2B5+CD133− subgroup of human glioma stem cells</title><title>Oncology reports</title><addtitle>Oncol Rep</addtitle><description>MicroRNAs (miRs) act as oncogenes or tumor-suppressor genes, and regulate the proliferation, apoptosis, invasion, differentiation, angiogenesis and behavior of glioma stem cells, which are important in glioma development and recurrence. The present study was performed to investigate the impact of miR-218-5p on stem cell properties and invasive ability of the A2B5+CD133− human glioma stem cell subgroup. qRT-PCR was used to detect miR-218-5p expression in non-cancerous brain and human glioma tissues, human glioma cell lines and human glioma stem cell lines. Lentivirus vectors encoding miR-218-5p and anti-miR-218-5p were constructed and stably transfected into A2B5+CD133− SHG-139s cells. Neurosphere formation Cell Counting Kit-8 (CCK-8) and Transwell assays, immunofluorescence and qRT-PCR analyses were used to explore the role of miR-218-5p in SHG-139s cells. qRT-PCR analysis showed that miR-218-5p expression was lower in human glioma tissues and cells than in non-cancerous brain tissues and normal human astrocyte cells, and lower in A2B5+CD133− (SHG-139s) cells than in CD133+ (SU2 and U87s) cells. The CCK-8 assay demonstrated that the growth curve was significantly inhibited in the miR-218-5p-SHG-139s cells compared to the miR-control, blank and anti-miR-218-5p groups. The neurosphere formation assay indicated that upregulation of miR-218-5p expression inhibited SHG-139s neurosphere formation. Immunofluorescence staining and qRT-PCR showed that miR-218-5p reduced stem cell marker (A2B5, nestin, PLAGL2, ALDH1 and Sox2) expression compared with the controls; however, immunofluorescence staining analysis showed that upregulation of miR-218-5p expression led to no difference in CD133 expression. miR-218-5p reduced SHG-139s cell invasiveness in the Transwell assay and reduced MMP9 expression as detected in qRT-PCR and immunofluorescence analyses. All differences were statistically significant. miR-218-5p expression was lower in human glioma tissues, cells and the A2B5+CD133− human glioma stem cell subgroup. miR-218-5p may be a tumor-suppressor gene in glioma that functions by upregulating miR-218-5p expression, which inhibits the stem cell properties and invasive properties of SHG-139s cells.</description><subject>A2B5+CD133− glioma stem cells</subject><subject>Adult</subject><subject>Brain Neoplasms - genetics</subject><subject>Brain Neoplasms - pathology</subject><subject>Brain research</subject><subject>Cancer therapies</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - genetics</subject><subject>Chemotherapy</subject><subject>Cloning</subject><subject>Female</subject><subject>Fluorescent Antibody Technique</subject><subject>Gene Expression Regulation, Neoplastic - genetics</subject><subject>Gene Knockdown Techniques</subject><subject>Genes</subject><subject>Genes, Tumor Suppressor</subject><subject>Genotype &amp; phenotype</subject><subject>Glioma</subject><subject>Glioma - genetics</subject><subject>Glioma - pathology</subject><subject>Growth factors</subject><subject>Humans</subject><subject>invasive ability</subject><subject>Laboratories</subject><subject>Male</subject><subject>Medical research</subject><subject>MicroRNAs - genetics</subject><subject>Middle Aged</subject><subject>miR-218-5p</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplastic Stem Cells - pathology</subject><subject>Patients</subject><subject>Penicillin</subject><subject>Polymerase Chain Reaction</subject><subject>stem cell properties</subject><subject>Stem cells</subject><subject>Studies</subject><subject>Surgery</subject><subject>Transfection</subject><subject>Tumors</subject><issn>1021-335X</issn><issn>1791-2431</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpd0d9r1TAUB_AgipvTN58lIIjgcs05SdrmcV5_TBgIouBbSdp0N6NtuqQdzL_A5_2J_iVLvXOCTwnkk8M550vIc-AbUWl8G-IGOaiNlFA9IIdQamAoBTzMd47AhFA_DsiTlC44x5IX-jE5wEKVCEV5SH4O_itDqJiaqB933vo50XnnaJrdQBvX93SKYXJx9i5RM7ZZXZnkrxw11vd-vqah-_PhBN-pN9v3IMTvXzc0LfY8hmVaX3fLYEZ63vswmH9101PyqDN9cs_uziPy_eOHb9tTdvbl0-ftyRlrBFQzk23VKYPYaiNVB9x10pYWlDDYlJpbic7JkjcuL0Nw4arCdm1nVdE0CNxqcURe7-vmQS4Xl-Z68GntwIwuLKmGUqFQgFxm-vI_ehGWOObuatACi0pqpbI63qsmhpSi6-op-sHE6xp4vWZSh1ivmdRrJpm_uCu62MG19_hvCBm82oM05QX7NqR7EyITinFkvCq0uAUrJZMF</recordid><startdate>20160201</startdate><enddate>20160201</enddate><creator>WU, ZHIWU</creator><creator>HAN, YONG</creator><creator>LI, YANYAN</creator><creator>LI, XUETAO</creator><creator>SUN, TING</creator><creator>CHEN, GUILIN</creator><creator>HUANG, YULUN</creator><creator>ZHOU, YOUXIN</creator><creator>DU, ZIWEI</creator><general>D.A. Spandidos</general><general>Spandidos Publications UK Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20160201</creationdate><title>miR-218-5p inhibits the stem cell properties and invasive ability of the A2B5+CD133− subgroup of human glioma stem cells</title><author>WU, ZHIWU ; HAN, YONG ; LI, YANYAN ; LI, XUETAO ; SUN, TING ; CHEN, GUILIN ; HUANG, YULUN ; ZHOU, YOUXIN ; DU, ZIWEI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c318t-4d8f5a22d9a45f10ef4b7b153a2c790b42ee470ce892303e86bfdfb56cc210b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>A2B5+CD133− glioma stem cells</topic><topic>Adult</topic><topic>Brain Neoplasms - genetics</topic><topic>Brain Neoplasms - pathology</topic><topic>Brain research</topic><topic>Cancer therapies</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - genetics</topic><topic>Chemotherapy</topic><topic>Cloning</topic><topic>Female</topic><topic>Fluorescent Antibody Technique</topic><topic>Gene Expression Regulation, Neoplastic - genetics</topic><topic>Gene Knockdown Techniques</topic><topic>Genes</topic><topic>Genes, Tumor Suppressor</topic><topic>Genotype &amp; phenotype</topic><topic>Glioma</topic><topic>Glioma - genetics</topic><topic>Glioma - pathology</topic><topic>Growth factors</topic><topic>Humans</topic><topic>invasive ability</topic><topic>Laboratories</topic><topic>Male</topic><topic>Medical research</topic><topic>MicroRNAs - genetics</topic><topic>Middle Aged</topic><topic>miR-218-5p</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplastic Stem Cells - pathology</topic><topic>Patients</topic><topic>Penicillin</topic><topic>Polymerase Chain Reaction</topic><topic>stem cell properties</topic><topic>Stem cells</topic><topic>Studies</topic><topic>Surgery</topic><topic>Transfection</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>WU, ZHIWU</creatorcontrib><creatorcontrib>HAN, YONG</creatorcontrib><creatorcontrib>LI, YANYAN</creatorcontrib><creatorcontrib>LI, XUETAO</creatorcontrib><creatorcontrib>SUN, TING</creatorcontrib><creatorcontrib>CHEN, GUILIN</creatorcontrib><creatorcontrib>HUANG, YULUN</creatorcontrib><creatorcontrib>ZHOU, YOUXIN</creatorcontrib><creatorcontrib>DU, ZIWEI</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Oncology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WU, ZHIWU</au><au>HAN, YONG</au><au>LI, YANYAN</au><au>LI, XUETAO</au><au>SUN, TING</au><au>CHEN, GUILIN</au><au>HUANG, YULUN</au><au>ZHOU, YOUXIN</au><au>DU, ZIWEI</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>miR-218-5p inhibits the stem cell properties and invasive ability of the A2B5+CD133− subgroup of human glioma stem cells</atitle><jtitle>Oncology reports</jtitle><addtitle>Oncol Rep</addtitle><date>2016-02-01</date><risdate>2016</risdate><volume>35</volume><issue>2</issue><spage>869</spage><epage>877</epage><pages>869-877</pages><issn>1021-335X</issn><eissn>1791-2431</eissn><abstract>MicroRNAs (miRs) act as oncogenes or tumor-suppressor genes, and regulate the proliferation, apoptosis, invasion, differentiation, angiogenesis and behavior of glioma stem cells, which are important in glioma development and recurrence. The present study was performed to investigate the impact of miR-218-5p on stem cell properties and invasive ability of the A2B5+CD133− human glioma stem cell subgroup. qRT-PCR was used to detect miR-218-5p expression in non-cancerous brain and human glioma tissues, human glioma cell lines and human glioma stem cell lines. Lentivirus vectors encoding miR-218-5p and anti-miR-218-5p were constructed and stably transfected into A2B5+CD133− SHG-139s cells. Neurosphere formation Cell Counting Kit-8 (CCK-8) and Transwell assays, immunofluorescence and qRT-PCR analyses were used to explore the role of miR-218-5p in SHG-139s cells. qRT-PCR analysis showed that miR-218-5p expression was lower in human glioma tissues and cells than in non-cancerous brain tissues and normal human astrocyte cells, and lower in A2B5+CD133− (SHG-139s) cells than in CD133+ (SU2 and U87s) cells. The CCK-8 assay demonstrated that the growth curve was significantly inhibited in the miR-218-5p-SHG-139s cells compared to the miR-control, blank and anti-miR-218-5p groups. The neurosphere formation assay indicated that upregulation of miR-218-5p expression inhibited SHG-139s neurosphere formation. Immunofluorescence staining and qRT-PCR showed that miR-218-5p reduced stem cell marker (A2B5, nestin, PLAGL2, ALDH1 and Sox2) expression compared with the controls; however, immunofluorescence staining analysis showed that upregulation of miR-218-5p expression led to no difference in CD133 expression. miR-218-5p reduced SHG-139s cell invasiveness in the Transwell assay and reduced MMP9 expression as detected in qRT-PCR and immunofluorescence analyses. All differences were statistically significant. miR-218-5p expression was lower in human glioma tissues, cells and the A2B5+CD133− human glioma stem cell subgroup. miR-218-5p may be a tumor-suppressor gene in glioma that functions by upregulating miR-218-5p expression, which inhibits the stem cell properties and invasive properties of SHG-139s cells.</abstract><cop>Greece</cop><pub>D.A. Spandidos</pub><pmid>26572167</pmid><doi>10.3892/or.2015.4418</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1021-335X
ispartof Oncology reports, 2016-02, Vol.35 (2), p.869-877
issn 1021-335X
1791-2431
language eng
recordid cdi_proquest_miscellaneous_1752351204
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects A2B5+CD133− glioma stem cells
Adult
Brain Neoplasms - genetics
Brain Neoplasms - pathology
Brain research
Cancer therapies
Cell Line, Tumor
Cell Proliferation - genetics
Chemotherapy
Cloning
Female
Fluorescent Antibody Technique
Gene Expression Regulation, Neoplastic - genetics
Gene Knockdown Techniques
Genes
Genes, Tumor Suppressor
Genotype & phenotype
Glioma
Glioma - genetics
Glioma - pathology
Growth factors
Humans
invasive ability
Laboratories
Male
Medical research
MicroRNAs - genetics
Middle Aged
miR-218-5p
Neoplasm Invasiveness
Neoplastic Stem Cells - pathology
Patients
Penicillin
Polymerase Chain Reaction
stem cell properties
Stem cells
Studies
Surgery
Transfection
Tumors
title miR-218-5p inhibits the stem cell properties and invasive ability of the A2B5+CD133− subgroup of human glioma stem cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T12%3A17%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=miR-218-5p%20inhibits%20the%20stem%20cell%20properties%20and%20invasive%20ability%20of%20the%20A2B5+CD133%E2%88%92%20subgroup%20of%20human%20glioma%20stem%20cells&rft.jtitle=Oncology%20reports&rft.au=WU,%20ZHIWU&rft.date=2016-02-01&rft.volume=35&rft.issue=2&rft.spage=869&rft.epage=877&rft.pages=869-877&rft.issn=1021-335X&rft.eissn=1791-2431&rft_id=info:doi/10.3892/or.2015.4418&rft_dat=%3Cproquest_cross%3E1752351204%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1932684955&rft_id=info:pmid/26572167&rfr_iscdi=true